Antihypertensive efficacy of once daily MK-521, a new nonsulfhydryl angiotensin-converting enzyme inhibitor

Enzyme Inhibitor ◽

Converting Enzyme ◽

Once Daily ◽

First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramipril

The American Journal of Cardiology ◽

10.1016/0002-9149(88)90219-6 ◽

1988 ◽

Vol 62 (4) ◽

pp. 239-245 ◽

Cited By ~ 9

Author(s):

Mary E. Heber ◽

Geoffrey S. Brigden ◽

Michael P. Caruana ◽

Avijit Lahiri ◽

Edward B. Raftery

Keyword(s):

Dose Response ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Once Daily ◽

Faculty Opinions recommendation of Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725125555.793502388 ◽

2014 ◽

Author(s):

Athanasios Manolis

Keyword(s):

Calcium Channel ◽

Calcium Channel Antagonist ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Dietary Salt ◽

Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

Journal of Human Hypertension ◽

10.1038/jhh.2013.6 ◽

2013 ◽

Vol 27 (8) ◽

pp. 479-486 ◽

Cited By ~ 23

Author(s):

G Bönner ◽

G L Bakris ◽

D Sica ◽

M A Weber ◽

W B White ◽

...

Keyword(s):

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Converting Enzyme Inhibitor ◽

Azilsartan Medoxomil

Twenty-four-hour blood pressure control using once daily treatment with a calcium antagonist or an angiotensin converting enzyme inhibitor

Journal of Hypertension ◽

10.1097/00004872-199112006-00170 ◽

1991 ◽

Vol 9 ◽

pp. S374 ◽

Cited By ~ 1

Author(s):

Ettore Malacco ◽

Roberto Fogari ◽

Franco Tettamanti ◽

Marina Magenta

Keyword(s):

Blood Pressure ◽

Calcium Antagonist ◽

Blood Pressure Control ◽

Enzyme Inhibitor ◽

Pressure Control ◽

Converting Enzyme ◽

Once Daily ◽

Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive Hypertensives

Hypertension ◽

10.1161/01.hyp.31.5.1088 ◽

1998 ◽

Vol 31 (5) ◽

pp. 1088-1096 ◽

Cited By ~ 83

Author(s):

Matthew R. Weir ◽

Steven G. Chrysant ◽

David A. McCarron ◽

Maria Canossa-Terris ◽

Jerome D. Cohen ◽

...

Keyword(s):

Calcium Channel ◽

Calcium Channel Antagonist ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Dietary Salt ◽

Twenty-four-hour blood pressure control using once daily treatment with a calcium antagonist or an angiotensin converting enzyme inhibitor

Journal of Hypertension ◽

10.1097/00004872-199112000-00170 ◽

1991 ◽

Vol 9 (6) ◽

pp. S374

Author(s):

Ettore Malacco ◽

Roberto Fogari ◽

Franco Tettamanti ◽

Marina Magenta

Keyword(s):

Blood Pressure ◽

Calcium Antagonist ◽

Blood Pressure Control ◽

Enzyme Inhibitor ◽

Pressure Control ◽

Converting Enzyme ◽

Once Daily ◽

Allergy & Clinical Immunology International - Journal of the World Allergy Organization ◽

Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema

10.1027/0838-1925.19.4.164 ◽

2007 ◽

Vol 19 (4) ◽

pp. 164-165

Author(s):

Byol Shin ◽

Richard Lockey

Keyword(s):

Enzyme Inhibitor ◽

Converting Enzyme ◽

AT1-Receptorblocker Versus Angiotensin Converting Enzyme Inhibitor in Acute Myocardial Infarction? Role of Dosage and Bradykinin on Remodeling, Hemodynamics and Mortality in the Rat Model

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)85064-4 ◽

1998 ◽

Vol 31 (2) ◽

pp. 311A

Author(s):

P Gaudron

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Rat Model ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Faculty Opinions recommendation of Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108262.565200 ◽

2008 ◽

Author(s):

Nikolaus Gravenstein ◽

Felipe Urdaneta

Keyword(s):

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Diuretic Therapy ◽

Noncardiac Surgery ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blocker Therapy ◽

Faculty Opinions recommendation of Chronic angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy combined with diuretic therapy is associated with increased episodes of hypotension in noncardiac surgery.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108262.564286 ◽

2008 ◽

Author(s):

John Augoustides

Keyword(s):

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Diuretic Therapy ◽

Noncardiac Surgery ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blocker Therapy ◽